National Weekly Bulletin

Year: Week:

NATIONAL WEEKLY INFLUENZA BULLETIN OF THE RUSSIAN FEDERATION

week 19 of 2023 (08.05.23 - 14.05.23)

Summary

Influenza and ARI incidence data. Influenza and other ARI activity in Russia decrease in comparison with previous week. The nationwide ILI and ARI morbidity level (39.9 per 10 000 of population) was lower than national baseline (70.0) by 43.0%.

Etiology of ILI & ARI. Among 3755 patients investigation 40 (1.1%) respiratory samples were positive for influenza, including 1 case of influenza A unsubtyped in 1 city, 1 case of influenza A(H1N1)pdm09 in 1 city, 1 case of influenza A(H3N2) in 1 city and 37 cases of influenza B in 13 cities.

No influenza viruses were isolated on MDCK cell culture. Since the beginning of the season 1208 influenza viruses were isolated on MDCK cell culture, including: 777 viruses A(H1N1)pdm09, 30 viruses A(H3N2) and 401 viruses B.

Antigenic characterization. Since the beginning of the season, 650 influenza A(H1N1)pdm09 viruses have been antigenically characterized by the NICs, including: Moscow (105) and Saint-Petersburg (545), 29 influenza A(H3N2) viruses in Moscow (2) and Saint-Petersburg (27) and 211 influenza B, including: Moscow (15) and Saint-Petersburg (196). All viruses A(H1N1)pdm09 were antigenically similar to reference strain A/Victoria/2570/2019 (H1N1)pdm09. 27 influenza A(H3N2) strains were similar to the reference virus A/Darwin/9/2021 and 2 influenza A(H3N2) viruses reacted with the reference virus antiserum to a 1:8 homologous titer. 209 influenza B viruses were antigenically similar to reference strain В/Austria/1359417/2021 and 2 influenza B viruses reacted with the reference virus antiserum to a 1:8 homologous titer.

Genetic analysis. Sequencing of 993 influenza viruses and isolates from primary clinical materials from patients was performed by NIC (Saint-Petersburg). According to phylogenetic analysis, 904 influenza A(H1N1)pdm09 viruses were assigned to genetic subgroup 6 B.1A.5a.2 and similar to reference virus A/Victoria/2570/2019 (H1N1)pdm09; 27 A(H3N2) viruses was assigned to subgroup 3C.2 a1b.2a.2 and similar to reference virus Bangladesh/4005/2020 (H3N2); 62 influenza type B viruses were assigned to genetic subgroup V1A.3a.2 reference virus B/Austria/1359417/2021.Susceptibility to antivirals. The sensitivity of 390 influenza viruses to neuraminidase inhibitors (oseltamivir, zanamivir) was studied in two NICs (Moscow, St. Petersburg), including 330 A(H1N1)pdm09 viruses and 10 A(H3N2) viruses in NIC (Saint-Petersburg) and 45 A(H1N1)pdm09 viruses and 5 B viruses in NIC (Moscow). All the viruses studied were sensitive to oseltamivir and zanamivir.

ARVI detections. The overall proportion of respiratory samples tested positive for other ARVI (PIV, ADV, RSV, RhV, CoV, MPV, BoV) was estimated in total as 14.0% (PCR).

In sentinel surveillance system clinical samples from 21 SARI patients were investigated by rRT-PCR for influenza, among them no positive cases recognized. Among 21 SARI samples 5 (23.8%) cases positive for ARVI detected including 3 cases of PIV, 1 case of RhV and 1 case of BoV infection. 3 (14.3%) of 21 SARI patients were positive for coronavirus SARS-CoV-2.

Clinical samples from 32 ILI/ARI patients were investigated for influenza by rRT-PCR, among them no positive cases recognized. Among 32 ILI/ARI samples 5 (15.6%) cases positive for ARVI detected including 3 cases of PIV and 2 cases of RhV infection. Among 32 ILI/ARI patients no positive cases of coronavirus SARS-CoV-2 recognized. 

COVID-19. Totally 22 323 212 cases and 398 736 deaths associated with COVID-19 were registered in Russia including 2 902 cases and 26 deaths in last 24 hours (on 12:00 of 15.05.2023). According to the data obtained by NIC in Saint-Petersburg totally 6321 clinical samples were PCR investigated in last week. Among them coronavirus SARS-CoV-2 detected in 340 (5.4%) cases.

Influenza and ARI morbidity data

Fig. 1. Influenza and ARVI morbidity in 61 cities under surveillance in Russia, seasons 2021/22 and 2022/23
Rates per 10 000 populationFig. 1. Influenza and ARVI morbidity in 61 cities under surveillance in Russia, seasons 2021/22 and 2022/23

Weeks

  • Morbidity 2022/23Morbidity 2022/23
  • Morbidity 2021/22Morbidity 2021/22
  • MEM baseline 2022/23MEM baseline 2022/23

Epidemiological data showed decrease of influenza and other ARI activity in Russia in comparison with previous week. The nationwide ILI and ARI morbidity level (39.9 per 10 000 of population) was lower than national baseline (70.0) by 43.0%.

Fig. 2. Comparative data on incidence rate of clinically diagnosed influenza, seasons 2021/22 and 2022/23
Rates per 10 000 populationFig. 2. Comparative data on incidence rate of clinically diagnosed influenza, seasons 2021/22 and 2022/23

Weeks

  • Season 2022/23Season 2022/23
  • Season 2021/22Season 2021/22
  • MEM baselineMEM baseline

Incidence rate of clinically diagnosed influenza decreased comparing to previous week and amounted to 0.056 per 10 000 of population, it was lower than pre-epidemic MEM baseline (0.060).

Fig. 3. Comparison of hospitalization rate with clinical diagnosis of influenza, seasons 2021/22 and 2022/23
Rates per 10 000 populationFig. 3. Comparison of hospitalization rate with clinical diagnosis of influenza, seasons 2021/22 and 2022/23

Weeks

  • Season 2022/23Season 2022/23
  • Season 2021/22Season 2021/22
  • MEM baselineMEM baseline

Hospitalization rate of clinically diagnosed influenza decreased comparing to previous week and amounted to 0.017 per 10 000 of population, it was lower than pre-epidemic MEM baseline (0.040).

Influenza and ARVI laboratory testing results

Cumulative results of influenza laboratory diagnosis by rRT-PCR were submitted by 46 RBLs and two WHO NICs. According to these data as a result of 3755 patients investigation 40 (1.1%) respiratory samples were positive for influenza, including 1 case of influenza A unsubtyped in 1 city, 1 case of influenza A(H1N1)pdm09 in 1 city, 1 case of influenza A(H3N2) in 1 city and 37 cases of influenza B in 13 cities.

No influenza viruses were isolated on MDCK cell culture. Since the beginning of the season 1208 influenza viruses were isolated on MDCK cell culture, including: 777 viruses A(H1N1)pdm09, 30 viruses A(H3N2) and 401 viruses B.

Antigenic characterization. Since the beginning of the season, 650 influenza A(H1N1)pdm09 viruses have been antigenically characterized by the NICs, including: Moscow (105) and Saint-Petersburg (545), 29 influenza A(H3N2) viruses in Moscow (2) and Saint-Petersburg (27) and 211 influenza B, including: Moscow (15) and Saint-Petersburg (196). All viruses A(H1N1)pdm09 were antigenically similar to reference strain A/Victoria/2570/2019 (H1N1)pdm09. 27 influenza A(H3N2) strains were similar to the reference virus A/Darwin/9/2021 and 2 influenza A(H3N2) viruses reacted with the reference virus antiserum to a 1:8 homologous titer. 209 influenza B viruses were antigenically similar to reference strain В/Austria/1359417/2021 and 2 influenza B viruses reacted with the reference virus antiserum to a 1:8 homologous titer.Genetic analysis. Sequencing of 993 influenza viruses and isolates from primary clinical materials from patients was performed by NIC (Saint-Petersburg). According to phylogenetic analysis, 904 influenza A(H1N1)pdm09 viruses were assigned to genetic subgroup 6 B.1A.5a.2 and similar to reference virus A/Victoria/2570/2019 (H1N1)pdm09; 27 A(H3N2) viruses was assigned to subgroup 3C.2 a1b.2a.2 and similar to reference virus Bangladesh/4005/2020 (H3N2); 62 influenza type B viruses were assigned to genetic subgroup V1A.3a.2 reference virus B/Austria/1359417/2021.Susceptibility to antivirals. The sensitivity of 390 influenza viruses to neuraminidase inhibitors (oseltamivir, zanamivir) was studied in two NICs (Moscow, St. Petersburg), including 330 A(H1N1)pdm09 viruses and 10 A(H3N2) viruses in NIC (Saint-Petersburg) and 45 A(H1N1)pdm09 viruses and 5 B viruses in NIC (Moscow). All the viruses studied were sensitive to oseltamivir and zanamivir.

Fig. 4. Geographic distribution of RT-PCR detected influenza viruses in cities under surveillance in Russia, week 19 of 2023
Fig. 4. Geographic distribution of RT-PCR detected influenza viruses in cities under surveillance in Russia, week 19 of 2023
PCR results
  • No dataNo data
  • No viruses detectedNo viruses detected
  • H1pdm09H1pdm09
  • H3H3
  • H3+H1pdm09H3+H1pdm09
  • BB
  • B+H1pdm09B+H1pdm09
  • B+H3B+H3
  • B+H3+H1pdm09B+H3+H1pdm09
  • A (not subt.)A (not subt.)
  • A (not subt.)+H1pdm09A (not subt.)+H1pdm09
  • A (not subt.)+H3A (not subt.)+H3
  • A (not subt.)+H3+H1pdm09A (not subt.)+H3+H1pdm09
  • A (not subt.)+BA (not subt.)+B
  • A (not subt.)+B+H1pdm09A (not subt.)+B+H1pdm09
  • A (not subt.)+B+H3A (not subt.)+B+H3
  • A (not subt.)+B+H3+H1pdm09A (not subt.)+B+H3+H1pdm09
Fig. 5. Monitoring of influenza viruses detection by RT-PCR in Russia, season 2022/23
Number of positive casesFig. 5. Monitoring of influenza viruses detection by RT-PCR in Russia, season 2022/23% positive

Weeks

  • H1pdm09H1pdm09
  • H3H3
  • BB
  • A (not subt.)A (not subt.)
  • % positive% positive
Fig. 6. Monitoring of ARVI detection by RT-PCR in Russia, season 2022/23
Number of positive casesFig. 6. Monitoring of ARVI detection by RT-PCR in Russia, season 2022/23

Weeks

  • PIVPIV
  • ADVADV
  • RSVRSV
  • RhVRhV
  • CoVCoV
  • MPVMPV
  • BoVBoV

ARVI detections. The overall proportion of respiratory samples tested positive for other ARVI (PIV, ADV, RSV, RhV, CoV, MPV, BoV) estimated as 14.0% of investigated samples by PCR.

Fig. 7. Monitoring of influenza viruses isolation in Russia, season 2022/23
Number of positive casesFig. 7. Monitoring of influenza viruses isolation in Russia, season 2022/23% positive

Weeks

  • H1pdm09H1pdm09
  • H3H3
  • BB
  • % positive% positive

Table 1. Results of influenza and other ARVI detection by RT-PCR in Russia, week 19 of 2023

  Number of  specimens / number of positive cases  % positive
Influenza
Number of specimens tested for influenza 3755 -
Influenza A (not subt.) 1 0,03%
Influenza A(H1)pdm09 1 0,03% 
Influenza A(H3) 1 0,03% 
Influenza B 37 1,0% 
All influenza 40 1,1%
Other ARVI
Number of specimens tested for ARVI 3622  -
PIV 83 2,3%
ADV 58 1,6%
RSV 49 1,4%
RhV 219 6,0%
CoV 60 1,7%
MPV 26 0,7%
BoV 12 0,3%
All ARVI 507 14,0%
SARS-CoV-2 (COVID-19)
Number of specimens tested for SARS-CoV-2 6321 -
SARS-CoV-2 340 5,4%
Fig. 8. Results of PCR detections of SARS-CoV-2 in Russia
Fig. 8. Results of PCR detections of SARS-CoV-2 in Russia
% positive
  • No dataNo data
  • less then 10%less then 10%
  • 10-20%10-20%
  • 20-30%20-30%
  • 30-40%30-40%
  • 40-50%40-50%
  • 50% and more50% and more

COVID-19. Totally 22 323 212 cases and 398 736 deaths associated with COVID-19 were registered in Russia including 2 902 cases and 26 deaths in last 24 hours (on 12:00 of 15.05.2023). According to the data obtained by NIC in Saint-Petersburg totally 6321 clinical samples were PCR investigated in last week. Among them coronavirus SARS-CoV-2 detected in 340 (5.4%) cases.

Table 2. Results of influenza viruses isolation in Russia, week 19 of 2023

  Number of specimens / number of viruses  % isolated viruses
Number of specimens 20 -
Influenza A(H1)pdm09 0 0,0% 
Influenza A(H3) 0 0,0% 
Influenza B 0 0,0% 
All influenza 0 0,0%

Sentinel influenza surveillance

Clinical samples from 21 SARI patients were investigated by rRT-PCR for influenza, among them no positive cases recognized. Among 21 SARI samples 5 (23.8%) cases positive for ARVI detected including 3 cases of PIV, 1 case of RhV and 1 case of BoV infection. 3 (14.3%) of 21 SARI patients were positive for coronavirus SARS-CoV-2. 

Clinical samples from 32 ILI/ARI patients were investigated for influenza by rRT-PCR, among them no positive cases recognized. Among 32 ILI/ARI samples 5 (15.6%) cases positive for ARVI detected including 3 cases of PIV and 2 cases of RhV infection. Among 32 ILI/ARI patients no positive cases of coronavirus SARS-CoV-2 recognized. 

Fig. 9. Monitoring of influenza viruses detection by RT-PCR among SARI patients in sentinel hospitals, season 2022/23
Number of positive casesFig. 9.  Monitoring of influenza viruses detection by RT-PCR among SARI patients in sentinel hospitals, season 2022/23% positive

Weeks

  • H1pdm09H1pdm09
  • H3H3
  • BB
  • A (not subt.)A (not subt.)
  • % positive% positive
Fig. 10. Monitoring of influenza viruses detection by RT-PCR among ILI/ARI patients in sentinel polyclinics, season 2022/23
Number of positive casesFig. 10.  Monitoring of influenza viruses detection by RT-PCR among ILI/ARI patients in sentinel polyclinics, season 2022/23% positive

Weeks

  • H1pdm09H1pdm09
  • H3H3
  • BB
  • A (not subt.)A (not subt.)
  • % positive% positive
Fig. 11. Monitoring of ARVI detection by RT-PCR among SARI patients in sentinel hospitals, season 2022/23
Number of positive casesFig. 11.  Monitoring of ARVI detection by RT-PCR among SARI patients in sentinel hospitals, season 2022/23

Weeks

  • PIVPIV
  • ADVADV
  • RSVRSV
  • RhVRhV
  • CoVCoV
  • MPVMPV
  • BoVBoV
Fig. 12. Monitoring of ARVI detection by RT-PCR among ILI/ARI patients in sentinel polyclinics, season 2022/23
Number of positive casesFig. 12.  Monitoring of ARVI detection by RT-PCR among ILI/ARI patients in sentinel polyclinics, season 2022/23

Weeks

  • PIVPIV
  • ADVADV
  • RSVRSV
  • RhVRhV
  • CoVCoV
  • MPVMPV
  • BoVBoV
Download PDF version